Silco Pharmaceuticals Limited (DSE: SILCOPHL)
Bangladesh
· Delayed Price · Currency is BDT 15.90
-0.10 (-0.62%)
At close: Jan 28, 2025
Silco Pharmaceuticals Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 27, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Market Capitalization | 1,651 | 1,754 | 2,533 | 2,741 | 2,709 | 2,325 | Upgrade
|
| Market Cap Growth | -15.19% | -30.74% | -7.58% | 1.15% | 16.52% | 0.16% | Upgrade
|
| Enterprise Value | 1,630 | 1,703 | 2,491 | 2,643 | 2,599 | 2,064 | Upgrade
|
| Last Close Price | 15.90 | 16.80 | 23.94 | 25.35 | 24.10 | 19.78 | Upgrade
|
| PE Ratio | 31.79 | 38.24 | 36.59 | 32.45 | 32.01 | 27.96 | Upgrade
|
| PS Ratio | 3.92 | 4.28 | 5.45 | 4.90 | 4.51 | 3.17 | Upgrade
|
| PB Ratio | 0.70 | 0.75 | 1.09 | 1.20 | 1.19 | 1.04 | Upgrade
|
| P/TBV Ratio | 0.88 | 0.75 | 1.09 | 1.20 | 1.19 | 1.04 | Upgrade
|
| P/FCF Ratio | - | 32375.63 | - | 43.53 | - | - | Upgrade
|
| P/OCF Ratio | 22.65 | 20.81 | 14.03 | 16.21 | 10.53 | 15.86 | Upgrade
|
| EV/Sales Ratio | 3.86 | 4.15 | 5.36 | 4.72 | 4.32 | 2.81 | Upgrade
|
| EV/EBITDA Ratio | 24.15 | 11.52 | 16.19 | 15.35 | 16.88 | 11.75 | Upgrade
|
| EV/EBIT Ratio | 25.92 | 28.78 | 37.09 | 27.11 | 32.74 | 21.29 | Upgrade
|
| EV/FCF Ratio | -226.59 | 31423.90 | - | 41.99 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | - | 0.00 | 0.00 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.13 | 0.06 | - | 0.02 | 0.05 | - | Upgrade
|
| Debt / FCF Ratio | - | 176.56 | - | 0.07 | - | - | Upgrade
|
| Asset Turnover | 0.15 | 0.15 | 0.17 | 0.21 | 0.22 | 0.28 | Upgrade
|
| Inventory Turnover | 0.65 | 0.63 | 0.71 | 0.82 | 0.96 | 1.18 | Upgrade
|
| Quick Ratio | 1.50 | 1.45 | 1.44 | 1.56 | 1.64 | 2.86 | Upgrade
|
| Current Ratio | 3.43 | 3.39 | 3.40 | 3.61 | 3.72 | 5.10 | Upgrade
|
| Return on Equity (ROE) | 2.21% | 1.96% | 3.01% | 3.71% | 3.75% | 3.76% | Upgrade
|
| Return on Assets (ROA) | 1.39% | 1.32% | 1.53% | 2.25% | 1.85% | 2.32% | Upgrade
|
| Return on Capital (ROIC) | 1.66% | 1.58% | 1.82% | 2.67% | 2.19% | 2.74% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.49% | 2.36% | 2.72% | 4.01% | 3.29% | 4.04% | Upgrade
|
| Earnings Yield | 3.15% | 2.62% | 2.73% | 3.08% | 3.12% | 3.58% | Upgrade
|
| FCF Yield | -0.44% | 0.00% | -0.06% | 2.30% | -4.40% | -1.01% | Upgrade
|
| Dividend Yield | 0.63% | 0.60% | 1.25% | 1.97% | 4.15% | 5.06% | Upgrade
|
| Payout Ratio | 36.98% | 41.72% | 45.43% | 74.15% | 73.25% | 22.11% | Upgrade
|
| Buyback Yield / Dilution | -0.96% | - | - | - | - | -28.88% | Upgrade
|
| Total Shareholder Return | -0.33% | 0.60% | 1.25% | 1.97% | 4.15% | -23.82% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.